Dougall WC - Search Results

1

The RANK/RANKL/OPG triad in cancer-induced bone diseases.

Dougall WC, Chaisson M. Dougall WC, et al. Cancer Metastasis Rev. 2006 Dec;25(4):541-9. doi: 10.1007/s10555-006-9021-3. Cancer Metastasis Rev. 2006. PMID: 17180711 Review.

2

RANK is essential for osteoclast and lymph node development.

Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J. Dougall WC, et al. Genes Dev. 1999 Sep 15;13(18):2412-24. doi: 10.1101/gad.13.18.2412. Genes Dev. 1999. PMID: 10500098 Free PMC article.

3

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.

Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET. Zhang J, et al. Cancer Res. 2003 Nov 15;63(22):7883-90. Cancer Res. 2003. PMID: 14633717

4

Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.

Chaisson ML, Branstetter DG, Derry JM, Armstrong AP, Tometsko ME, Takeda K, Akira S, Dougall WC. Chaisson ML, et al. Among authors: dougall wc. J Biol Chem. 2004 Dec 24;279(52):54841-8. doi: 10.1074/jbc.M406392200. Epub 2004 Oct 14. J Biol Chem. 2004. PMID: 15485831 Free article.

5

[Monoclonal antibody targeting RANKL as a therapy for cancer-induced bone diseases].

Dougall W, Chaisson M. Dougall W, et al. Clin Calcium. 2006 Apr;16(4):627- 35. Clin Calcium. 2006. PMID: 16582514 Review. Japanese.

6

Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats.

Roudier MP, Bain SD, Dougall WC. Roudier MP, et al. Among authors: dougall wc. Clin Exp Metastasis. 2006;23(3-4):167-75. doi: 10.1007/s10585-006-9026-x. Epub 2006 Aug 16. Clin Exp Metastasis. 2006. PMID: 16912914

7

RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini.

Gonzalez-Suarez E, Branstetter D, Armstrong A, Dinh H, Blumberg H, Dougall WC. Gonzalez-Suarez E, et al. Among authors: dougall wc. Mol Cell Biol. 2007 Feb;27(4):1442-54. doi: 10.1128/MCB.01298-06. Epub 2006 Dec 4. Mol Cell Biol. 2007. PMID: 17145767 Free PMC article.

8

Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection.

Miller RE, Branstetter D, Armstrong A, Kennedy B, Jones J, Cowan L, Bussiere J, Dougall WC. Miller RE, et al. Among authors: dougall wc. J Immunol. 2007 Jul 1;179(1):266-74. doi: 10.4049/jimmunol.179.1.266. J Immunol. 2007. PMID: 17579046

9

RANK ligand as a therapeutic target for bone metastases and multiple myeloma.

Roodman GD, Dougall WC. Roodman GD, et al. Among authors: dougall wc. Cancer Treat Rev. 2008 Feb;34(1):92-101. doi: 10.1016/j.ctrv.2007.09.002. Epub 2007 Oct 26. Cancer Treat Rev. 2008. PMID: 17964729 Review.

10

RANKL inhibition: from mice to men (and women).

Stolina M, Kostenuik PJ, Dougall WC, Fitzpatrick LA, Zack DJ. Stolina M, et al. Among authors: dougall wc. Adv Exp Med Biol. 2007;602:143-50. doi: 10.1007/978-0-387-72009-8_18. Adv Exp Med Biol. 2007. PMID: 17966399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters